PFF Webinar Library

fda-stamp-of-approval-and-medications

The FDA's Drug Approval Process

Fri, Sep 28, 2018

Learn about FDA requirements for drug approval, frequently used FDA terminology, and therapies for IPF.

Dr. Banu Karimi-Shah of the FDA - Center for Drug Evaluation and Research, Division of Pulmonary, Allergy, and Rheumatology Products joins us to give background information on the FDA requirements for drug approval, frequently used FDA terminology, and therapies for IPF.

Recent Webinars

  • HRCT Scan
    Jan
    25
    2023

    Diagnosing ILD: Elements of a Comprehensive Evaluation

    View Webinar
  • pulmonary-hypertension
    Oct
    26
    2022

    Pulmonary Hypertension and Interstitial Lung Disease: Diagnosis and Disease Management

    View Webinar
  • ILD Day graphic
    Sep
    14
    2022

    Progressive Pulmonary Fibrosis: What Patients Need to Know

    View Webinar
  • capsules-159211
    Aug
    24
    2022

    Clinical Trials: How to Get Involved and What to Expect

    View Webinar